3D-AttenNet model can predict clinically significant prostate cancer in PI-RADS category 3 patients: a retrospective multicenter study

Abstract Purposes The presence of clinically significant prostate cancer (csPCa) is equivocal for patients with prostate imaging reporting and data system (PI-RADS) category 3. We aim to develop deep learning models for re-stratify risks in PI-RADS category 3 patients. Methods This retrospective stu...

Full description

Saved in:
Bibliographic Details
Main Authors: Jie Bao, Litao Zhao, Xiaomeng Qiao, Zhenkai Li, Yanting Ji, Yueting Su, Libiao Ji, Junkang Shen, Jiangang Liu, Jie Tian, Ximing Wang, Hailin Shen, Chunhong Hu
Format: Article
Language:English
Published: SpringerOpen 2025-01-01
Series:Insights into Imaging
Subjects:
Online Access:https://doi.org/10.1186/s13244-024-01896-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571571622903808
author Jie Bao
Litao Zhao
Xiaomeng Qiao
Zhenkai Li
Yanting Ji
Yueting Su
Libiao Ji
Junkang Shen
Jiangang Liu
Jie Tian
Ximing Wang
Hailin Shen
Chunhong Hu
author_facet Jie Bao
Litao Zhao
Xiaomeng Qiao
Zhenkai Li
Yanting Ji
Yueting Su
Libiao Ji
Junkang Shen
Jiangang Liu
Jie Tian
Ximing Wang
Hailin Shen
Chunhong Hu
author_sort Jie Bao
collection DOAJ
description Abstract Purposes The presence of clinically significant prostate cancer (csPCa) is equivocal for patients with prostate imaging reporting and data system (PI-RADS) category 3. We aim to develop deep learning models for re-stratify risks in PI-RADS category 3 patients. Methods This retrospective study included a bi-parametric MRI of 1567 consecutive male patients from six centers (Centers 1–6) between Jan 2015 and Dec 2020. Deep learning models with double channel attention modules based on MRI (AttenNet) for predicting PCa and csPCa were constructed separately. Each model was first pretrained using 1144 PI-RADS 1–2 and 4–5 images and then retrained using 238 PI-RADS 3 images from three training centers (centers 1–3), and tested using 185 PI-RADS 3 images from the other three testing centers (centers 4–6). Results Our AttenNet models achieved excellent prediction performances in testing cohort of center 4–6 with the area under the receiver operating characteristic curves (AUC) of 0.795 (95% CI: [0.700, 0.891]), 0.963 (95% CI: [0.915, 1]) and 0.922 (95% CI: [0.810, 1]) in predicting PCa, and the corresponding AUCs were 0.827 (95% CI: [0.703, 0.952]) and 0.926 (95% CI: [0.846, 1]) in predicting csPCa in testing cohort of center 4 and center 5. In particular, 71.1% to 92.2% of non-csPCa patients were identified by our model in three testing cohorts, who can spare from invasive biopsy or RP procedure. Conclusions Our model offers a noninvasive screening clinical tool to re-stratify risks in PI-RADS 3 patients, thereby reducing unnecessary invasive biopsies and improving the effectiveness of biopsies. Critical relevance statement The deep learning model with MRI can help to screen out csPCa in PI-RADS category 3. Key Points AttenNet models included channel attention and soft attention modules. 71.1–92.2% of non-csPCa patients were identified by the AttenNet model. The AttenNet models can be a screen clinical tool to re-stratify risks in PI-RADS 3 patients. Graphical Abstract
format Article
id doaj-art-2bb2ae340e304e0583142fb062f416a2
institution Kabale University
issn 1869-4101
language English
publishDate 2025-01-01
publisher SpringerOpen
record_format Article
series Insights into Imaging
spelling doaj-art-2bb2ae340e304e0583142fb062f416a22025-02-02T12:27:55ZengSpringerOpenInsights into Imaging1869-41012025-01-0116111310.1186/s13244-024-01896-13D-AttenNet model can predict clinically significant prostate cancer in PI-RADS category 3 patients: a retrospective multicenter studyJie Bao0Litao Zhao1Xiaomeng Qiao2Zhenkai Li3Yanting Ji4Yueting Su5Libiao Ji6Junkang Shen7Jiangang Liu8Jie Tian9Ximing Wang10Hailin Shen11Chunhong Hu12Department of Radiology, The First Affiliated Hospital of Soochow UniversitySchool of Engineering Medicine, Beihang UniversityDepartment of Radiology, The First Affiliated Hospital of Soochow UniversityDepartment of Radiology, Suzhou Kowloon Hospital, Shanghai Jiaotong University School of MedicineDepartment of Radiology, The First Affiliated Hospital of Soochow UniversityDepartment of Radiology, The People’s Hospital of TaizhouDepartment of Radiology, Changshu No.1 People’s HospitalDepartment of Radiology, The Second Affiliated Hospital of Soochow UniversitySchool of Engineering Medicine, Beihang UniversitySchool of Engineering Medicine, Beihang UniversityDepartment of Radiology, The First Affiliated Hospital of Soochow UniversityDepartment of Radiology, Suzhou Kowloon Hospital, Shanghai Jiaotong University School of MedicineDepartment of Radiology, The First Affiliated Hospital of Soochow UniversityAbstract Purposes The presence of clinically significant prostate cancer (csPCa) is equivocal for patients with prostate imaging reporting and data system (PI-RADS) category 3. We aim to develop deep learning models for re-stratify risks in PI-RADS category 3 patients. Methods This retrospective study included a bi-parametric MRI of 1567 consecutive male patients from six centers (Centers 1–6) between Jan 2015 and Dec 2020. Deep learning models with double channel attention modules based on MRI (AttenNet) for predicting PCa and csPCa were constructed separately. Each model was first pretrained using 1144 PI-RADS 1–2 and 4–5 images and then retrained using 238 PI-RADS 3 images from three training centers (centers 1–3), and tested using 185 PI-RADS 3 images from the other three testing centers (centers 4–6). Results Our AttenNet models achieved excellent prediction performances in testing cohort of center 4–6 with the area under the receiver operating characteristic curves (AUC) of 0.795 (95% CI: [0.700, 0.891]), 0.963 (95% CI: [0.915, 1]) and 0.922 (95% CI: [0.810, 1]) in predicting PCa, and the corresponding AUCs were 0.827 (95% CI: [0.703, 0.952]) and 0.926 (95% CI: [0.846, 1]) in predicting csPCa in testing cohort of center 4 and center 5. In particular, 71.1% to 92.2% of non-csPCa patients were identified by our model in three testing cohorts, who can spare from invasive biopsy or RP procedure. Conclusions Our model offers a noninvasive screening clinical tool to re-stratify risks in PI-RADS 3 patients, thereby reducing unnecessary invasive biopsies and improving the effectiveness of biopsies. Critical relevance statement The deep learning model with MRI can help to screen out csPCa in PI-RADS category 3. Key Points AttenNet models included channel attention and soft attention modules. 71.1–92.2% of non-csPCa patients were identified by the AttenNet model. The AttenNet models can be a screen clinical tool to re-stratify risks in PI-RADS 3 patients. Graphical Abstracthttps://doi.org/10.1186/s13244-024-01896-1Deep learningMRIClinically significant prostate cancerPI-RADS
spellingShingle Jie Bao
Litao Zhao
Xiaomeng Qiao
Zhenkai Li
Yanting Ji
Yueting Su
Libiao Ji
Junkang Shen
Jiangang Liu
Jie Tian
Ximing Wang
Hailin Shen
Chunhong Hu
3D-AttenNet model can predict clinically significant prostate cancer in PI-RADS category 3 patients: a retrospective multicenter study
Insights into Imaging
Deep learning
MRI
Clinically significant prostate cancer
PI-RADS
title 3D-AttenNet model can predict clinically significant prostate cancer in PI-RADS category 3 patients: a retrospective multicenter study
title_full 3D-AttenNet model can predict clinically significant prostate cancer in PI-RADS category 3 patients: a retrospective multicenter study
title_fullStr 3D-AttenNet model can predict clinically significant prostate cancer in PI-RADS category 3 patients: a retrospective multicenter study
title_full_unstemmed 3D-AttenNet model can predict clinically significant prostate cancer in PI-RADS category 3 patients: a retrospective multicenter study
title_short 3D-AttenNet model can predict clinically significant prostate cancer in PI-RADS category 3 patients: a retrospective multicenter study
title_sort 3d attennet model can predict clinically significant prostate cancer in pi rads category 3 patients a retrospective multicenter study
topic Deep learning
MRI
Clinically significant prostate cancer
PI-RADS
url https://doi.org/10.1186/s13244-024-01896-1
work_keys_str_mv AT jiebao 3dattennetmodelcanpredictclinicallysignificantprostatecancerinpiradscategory3patientsaretrospectivemulticenterstudy
AT litaozhao 3dattennetmodelcanpredictclinicallysignificantprostatecancerinpiradscategory3patientsaretrospectivemulticenterstudy
AT xiaomengqiao 3dattennetmodelcanpredictclinicallysignificantprostatecancerinpiradscategory3patientsaretrospectivemulticenterstudy
AT zhenkaili 3dattennetmodelcanpredictclinicallysignificantprostatecancerinpiradscategory3patientsaretrospectivemulticenterstudy
AT yantingji 3dattennetmodelcanpredictclinicallysignificantprostatecancerinpiradscategory3patientsaretrospectivemulticenterstudy
AT yuetingsu 3dattennetmodelcanpredictclinicallysignificantprostatecancerinpiradscategory3patientsaretrospectivemulticenterstudy
AT libiaoji 3dattennetmodelcanpredictclinicallysignificantprostatecancerinpiradscategory3patientsaretrospectivemulticenterstudy
AT junkangshen 3dattennetmodelcanpredictclinicallysignificantprostatecancerinpiradscategory3patientsaretrospectivemulticenterstudy
AT jiangangliu 3dattennetmodelcanpredictclinicallysignificantprostatecancerinpiradscategory3patientsaretrospectivemulticenterstudy
AT jietian 3dattennetmodelcanpredictclinicallysignificantprostatecancerinpiradscategory3patientsaretrospectivemulticenterstudy
AT ximingwang 3dattennetmodelcanpredictclinicallysignificantprostatecancerinpiradscategory3patientsaretrospectivemulticenterstudy
AT hailinshen 3dattennetmodelcanpredictclinicallysignificantprostatecancerinpiradscategory3patientsaretrospectivemulticenterstudy
AT chunhonghu 3dattennetmodelcanpredictclinicallysignificantprostatecancerinpiradscategory3patientsaretrospectivemulticenterstudy